Drug safety during pregnancy and lactation -

12.00-12.15 The Finnish TIS in a nutshell - 30 years of counseling for risks and safe use of medications during pregnancy and lactation, Dr. Heli Malm, University of Helsinki, Finland (15 min)
12.15-12.45 Safe use of medicines during pregnancy – access and updating register-based information to the public and health care professionals in Sweden, Dr. Ulrika Norby, Stockholm, Sweden (25+5 min)
12.45-13.15 Signal detection methods in assessing prenatal exposure to prescription medications, Hannah Johnson, St George´s University of London, UK (25+5 min)
13.15-13.45 Socioeconomic differences in use of antiseizure medication during pregnancy in Nordic countries – promoting equity through counseling, Dr. Maarit Leinonen, Helsinki University Hospital and Finnish Institute for Health and Welfare, Helsinki, Finland (25+5 min)
Coffee and networking break
14.15-14.45 Introducing a novel approach investigating placental transporter mediated drug interactions and risks to the fetus, Suvi-Kukka Tuomi, University of Helsinki, Finland (25+5 min)
14.45-15.15 Prenatal exposure to SSRIs and offspring depression – follow up into adulthood, Dr. Heli Malm, HUS and University of Helsinki, Finland (25+5 min)
15.15-15.30 Increasing use of ADHD medicines during pregnancy, Iia Reiju, University of Helsinki, Finland (10+5 min)
15.30-15.45 Why do we still have to counsel on isotretinoin exposures occurring during pregnancy, Bianca Nilsson, University of Helsinki, Finland (10+5 min)
15.45-16.00 Closing words, Dr. Heli Malm and Dr. Maarit Leinonen, University of Helsinki and Helsinki University Hospital, Finland